Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p

miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42

(2013) Yuefeng Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

(2012) M. K. Gleason et al.   BLOOD

Tim-3, a negative regulator of anti-tumor immunity

(2012) Ana Carrizosa Anderson   CURRENT OPINION IN IMMUNOLOGY

MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene

(2012) Shengtao Qu et al.   PLoS One

MicroRNAs, the DNA damage response and cancer

(2011) Maikel D. Wouters et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker

(2011) M. Jan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells

(2010) Yoshikane Kikushige et al.   Cell Stem Cell

MicroRNAs in cancer — from research to therapy

(2009) William C.S. Cho   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

MicroRNAs: Novel regulators in the hallmarks of human cancer

(2009) Kai Ruan et al.   CANCER LETTERS

A role for microRNAs in the development of the immune system and in the pathogenesis of cancer

(2008) Chryssa Kanellopoulou et al.   SEMINARS IN CANCER BIOLOGY

let-7 microRNAs in development, stem cells and cancer

(2008) Ingo Büssing et al.   TRENDS IN MOLECULAR MEDICINE